{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:05:01Z","timestamp":1789625101517,"version":"build-2803163510"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"34","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Interstitial lung disease (ILD) is a major cause of morbidity and mortality in systemic sclerosis (SSc); yet, data from Middle Eastern populations remain limited. This study aimed to describe clinical characteristics, pulmonary involvement, and predictors of ILD in a Jordanian SSc cohort. A retrospective analysis was conducted on 129 adult patients with confirmed SSc based on the 2013 American College of Rheumatology\/European Alliance of Associations for Rheumatology classification criteria or rheumatologist-confirmed diagnosis, all of whom had available high-resolution computed tomography (HRCT) scans. ILD was defined by fibrotic bands, ground-glass opacities, and honeycombing on HRCT, interpreted by an experienced radiologist. Patients were categorized into an old cohort (pre-2019, n\u2005=\u200571) and a new cohort (2019 or later, n\u2005=\u200558). Demographic, clinical, serologic, pulmonary function, and radiologic data were analyzed. Multivariable logistic regression was used to identify predictors of ILD. The cohort was predominantly female (90%) with a mean disease duration of 13.4 years. Mean age at symptom onset was 40.7\u2005\u00b1\u200513 years, with a diagnostic delay of 3.4\u2005\u00b1\u20055.1 years. ILD was present in 58.9% of patients and was more frequent in diffuse cutaneous SSc (dcSSc) compared with limited cutaneous SSc (77.2% vs 44.4%), with dcSSc associated with 2.82-fold higher odds of ILD (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). HRCT was performed a mean of 6.9 years after diagnosis, indicating delayed ILD assessment. ILD prevalence was higher in the new cohort (69% vs 50.7%). Pulmonary arterial hypertension (PAH) occurred in 27.1% and was associated with ILD (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.015). Patients with ILD had significantly lower diffusing capacity of the lung for carbon monoxide (DLCO), forced expiratory volume in 1 second, and forced vital capacity. Independent predictors of ILD included dcSSc, anti-Scl70 antibody positivity, PAH, and reduced DLCO. Treatment patterns differed between cohorts, with increased use of mycophenolate and nintedanib in the new cohort. Overall mortality was 11.6%, with ILD present in 80% of deaths. ILD is highly prevalent in Jordanian patients with SSc and is strongly associated with the diffuse disease subtype, anti-Scl70 positivity, PAH, and reduced DLCO. Delayed HRCT assessment may underestimate the true incidence. Early screening and adherence to international guidelines are essential to improve detection and outcomes.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050368","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T17:06:56Z","timestamp":1787332016000},"page":"e50368","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Identifying predictors of systemic sclerosis-associated interstitial lung disease"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5574-2939","authenticated-orcid":false,"given":"Fatima","family":"Alnaimat","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salameh","family":"Al-Halaseh","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Ismail","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7573-0048","authenticated-orcid":false,"given":"Moath","family":"Fateh","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudqi","family":"Allouzi","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT, King Hussein Cancer Center (KHCC), Al-Jubeiha, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Almallah","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwan H.","family":"Adwan","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ula","family":"Qasem","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Al Oweidat","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Pulmonary, Sleep Medicine and Critical Care, School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Samara","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, School of Medicine, The University of Jordan, Amman, Jordan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khader N.","family":"Mustafa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology, School of Medicine, The University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260917","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder.","volume":"117","author":"Varga","year":"2007","journal-title":"J Clin Invest"},{"key":"R2-20260917","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis.","volume":"401","author":"Volkmann","year":"2023","journal-title":"Lancet"},{"key":"R3-20260917","doi-asserted-by":"crossref","first-page":"109267","DOI":"10.1016\/j.clim.2023.109267","article-title":"Global, regional, and national incidence and prevalence of systemic sclerosis.","volume":"248","author":"Tian","year":"2023","journal-title":"Clin Immunol"},{"key":"R4-20260917","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/BOR.0000000000001063","article-title":"A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018-2024.","volume":"37","author":"Good","year":"2025","journal-title":"Curr Opin Rheumatol"},{"key":"R5-20260917","doi-asserted-by":"crossref","first-page":"221","DOI":"10.5114\/reum.2019.87619","article-title":"Systemic sclerosis - multidisciplinary disease: clinical features and treatment.","volume":"57","author":"Sobolewski","year":"2019","journal-title":"Reumatologia"},{"key":"R6-20260917","first-page":"1567","article-title":"Systemic sclerosis: one year in review 2023.","volume":"41","author":"Di Battista","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"R7-20260917","doi-asserted-by":"crossref","first-page":"103330","DOI":"10.1016\/j.autrev.2023.103330","article-title":"Renal involvement in systemic sclerosis.","volume":"22","author":"Scheen","year":"2023","journal-title":"Autoimmun Rev"},{"key":"R8-20260917","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semarthrit.2013.05.002","article-title":"Neurologic involvement in scleroderma: a systematic review.","volume":"43","author":"Amaral","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"R9-20260917","doi-asserted-by":"crossref","first-page":"101668","DOI":"10.1016\/j.berh.2021.101668","article-title":"Cardiac involvement in systemic sclerosis: getting to the heart of the matter.","volume":"35","author":"Bruni","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R10-20260917","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1586\/egh.13.22","article-title":"Systemic sclerosis and the gut.","volume":"7","author":"Butt","year":"2013","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R11-20260917","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-030-63046-1_10","article-title":"Systemic sclerosis and pulmonary disease.","volume":"1303","author":"Ngo","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"R12-20260917","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002.","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R13-20260917","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis.","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"R14-20260917","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated interstitial lung disease.","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R15-20260917","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3899\/jrheum.170307","article-title":"All-cause healthcare costs and mortality in patients with systemic sclerosis with lung involvement.","volume":"45","author":"Fischer","year":"2018","journal-title":"J Rheumatol"},{"key":"R16-20260917","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S2665-9913(19)30144-4","article-title":"The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements.","volume":"2","author":"Hoffmann-Vold","year":"2020","journal-title":"Lancet Rheumatol"},{"key":"R17-20260917","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s10067-022-06408-4","article-title":"Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.","volume":"42","author":"Chatterjee","year":"2023","journal-title":"Clin Rheumatol"},{"key":"R18-20260917","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1080\/1744666X.2023.2198212","article-title":"Recent innovations in the screening and diagnosis of systemic sclerosis-associated interstitial lung disease.","volume":"19","author":"Makol","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"R19-20260917","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/OARRR.S226695","article-title":"Interstitial lung disease in systemic sclerosis: focus on early detection and intervention.","volume":"11","author":"Fischer","year":"2019","journal-title":"Open Access Rheumatol"},{"key":"R20-20260917","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/acr.22394","article-title":"Interstitial lung disease in undifferentiated forms of connective tissue disease.","volume":"67","author":"Fischer","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"R21-20260917","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1002\/art.39405","article-title":"Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease.","volume":"67","author":"Suliman","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R22-20260917","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3899\/jrheum.171362","article-title":"Performance of forced vital capacity and lung diffusion cutpoints for associated radiographic interstitial lung disease in systemic sclerosis.","volume":"45","author":"Showalter","year":"2018","journal-title":"J Rheumatol"},{"key":"R23-20260917","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system.","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"R24-20260917","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/art.39166","article-title":"Predictive value of serial high-resolution computed tomography analyses and concurrent lung function tests in systemic sclerosis.","volume":"67","author":"Hoffmann-Vold","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R25-20260917","first-page":"S15","article-title":"Systemic sclerosis-associated interstitial lung disease: Diagnostic approaches and challenges.","volume":"31","author":"Fairley","year":"2024","journal-title":"Rev Colomb Reumatol"},{"key":"R26-20260917","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/23971983211064463","article-title":"Diagnosis and monitoring of systemic sclerosis-associated interstitial lung disease using high-resolution computed tomography.","volume":"7","author":"Khanna","year":"2022","journal-title":"J Scleroderma Relat Disord"},{"key":"R27-20260917","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/1753465817713680","article-title":"Evaluation and management approaches for scleroderma lung disease.","volume":"11","author":"Schoenfeld","year":"2017","journal-title":"Ther Adv Respir Dis"},{"key":"R28-20260917","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5339\/qmj.2019.16","article-title":"Characteristics of patients with systemic sclerosis living in Qatar.","volume":"2019","author":"Alam","year":"2019","journal-title":"Qatar Med J"},{"key":"R29-20260917","doi-asserted-by":"crossref","first-page":"e284","DOI":"10.1016\/j.lpm.2019.07.037","article-title":"Clinical and serological profile of systemic sclerosis in Tunisia: a retrospective observational study.","volume":"48","author":"Ben Salah","year":"2019","journal-title":"Presse Med"},{"key":"R30-20260917","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/23971983221145788","article-title":"Comprehensive description of the prevalence, serological and clinical characteristics, and visceral involvement of systemic sclerosis (scleroderma) in a large cohort from the United Arab Emirates Systemic Sclerosis Registry.","volume":"8","author":"Namas","year":"2023","journal-title":"J Scleroderma Relat Disord"},{"key":"R31-20260917","doi-asserted-by":"crossref","first-page":"P13","DOI":"10.1186\/ar3614","article-title":"Prevalence of interstitial lung disease among patients with systemic sclerosis in Iraqi Kurdistan.","volume":"14","author":"Qaradakhy","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"R32-20260917","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/ijmbs.ijmbs_36_20","article-title":"Demographic characteristics and clinical manifestations of systemic sclerosis in Benghazi, Libya.","volume":"12","author":"Elbraky","year":"2020","journal-title":"Ibnosina J Med Biomed Sci"},{"key":"R33-20260917","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative.","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"R34-20260917","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s11926-010-0095-0","article-title":"Imaging lung disease in systemic sclerosis.","volume":"12","author":"Strollo","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"R35-20260917","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.3390\/diagnostics11111960","article-title":"High-resolution computed tomography: lights and shadows in improving care for SSc-ILD patients.","volume":"11","author":"Ruaro","year":"2021","journal-title":"Diagnostics"},{"key":"R36-20260917","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1161\/hc4801.100076","article-title":"Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects.","volume":"104","author":"McQuillan","year":"2001","journal-title":"Circulation"},{"key":"R37-20260917","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-7120-8-25","article-title":"Echocardiography may help detect pulmonary vasculopathy in the early stages of pulmonary artery hypertension associated with systemic sclerosis.","volume":"8","author":"Serra","year":"2010","journal-title":"Cardiovasc Ultrasound"},{"key":"R38-20260917","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00296-024-05535-2","article-title":"Systemic sclerosis associated respiratory involvement: scopus-based analysis of articles in 2013-2022.","volume":"44","author":"Doskaliuk","year":"2024","journal-title":"Rheumatol Int"},{"key":"R39-20260917","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/art.42860","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases.","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R40-20260917","doi-asserted-by":"crossref","first-page":"A311","DOI":"10.1016\/j.autrev.2009.11.003","article-title":"Geoepidemiology of systemic sclerosis.","volume":"9","author":"Ranque","year":"2010","journal-title":"Autoimmun Rev"},{"key":"R41-20260917","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ejr.2013.01.005","article-title":"Frequency of disease subsets and patterns of organ involvement among Egyptian patients with systemic sclerosis \u2013 a retrospective study.","volume":"35","author":"Abdel Moneim","year":"2013","journal-title":"Egypt Rheumatol"},{"key":"R42-20260917","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13075-016-1127-6","article-title":"Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families.","volume":"18","author":"Kuo","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"R43-20260917","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","article-title":"The registry of the German network for systemic scleroderma: frequency of disease subsets and patterns of organ involvement.","volume":"47","author":"Hunzelmann","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"R44-20260917","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.1016\/S2665-9913(22)00217-X","article-title":"Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort.","volume":"4","author":"Elhai","year":"2022","journal-title":"Lancet Rheumatol"},{"key":"R45-20260917","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort.","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"R46-20260917","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1136\/annrheumdis-2018-213201","article-title":"Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model.","volume":"77","author":"Wu","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"R47-20260917","article-title":"ERS\/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease.","volume":"85","author":"Antoniou","year":"2025","journal-title":"Ann Rheum Dis"},{"key":"R48-20260917","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/art.40441","article-title":"Screening high-resolution computed tomography of the chest to detect interstitial lung disease in systemic sclerosis: a global survey of rheumatologists.","volume":"70","author":"Bernstein","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R49-20260917","doi-asserted-by":"crossref","first-page":"392","DOI":"10.31138\/mjr.211224.alf","article-title":"Interstitial lung disease and pulmonary arterial hypertension screening practices in systemic sclerosis: survey insights of rheumatologists in the Middle East and North Africa Region.","volume":"36","author":"Namas","year":"2025","journal-title":"Mediterr J Rheumatol"},{"key":"R50-20260917","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s12016-022-08946-w","article-title":"Systemic sclerosis-specific antibodies: novel and classical biomarkers.","volume":"64","author":"Cavazzana","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"R51-20260917","doi-asserted-by":"crossref","first-page":"e8980","DOI":"10.1097\/MD.0000000000008980","article-title":"Clinical and serological features of systemic sclerosis in a multicenter African American cohort: analysis of the genome research in African American scleroderma patients clinical database.","volume":"96","author":"Morgan","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R52-20260917","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","article-title":"Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease.","volume":"201","author":"Khanna","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"R53-20260917","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/art.38702","article-title":"Interstitial lung disease associated with systemic sclerosis and idiopathic pulmonary fibrosis.","volume":"66","author":"Herzog","year":"2014","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"key":"R54-20260917","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.24267","article-title":"Survival in pulmonary hypertension associated with the scleroderma spectrum of diseases: impact of interstitial lung disease.","volume":"60","author":"Mathai","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R55-20260917","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/01.rti.0000213572.16904.40","article-title":"Significance of ground-glass opacity on HRCT in long-term follow-up of patients with systemic sclerosis.","volume":"22","author":"Shah","year":"2007","journal-title":"J Thorac Imaging"},{"key":"R56-20260917","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2214\/ajr.170.3.9490955","article-title":"Systemic sclerosis: using high-resolution CT to detect lung disease in children.","volume":"170","author":"Seely","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"R57-20260917","first-page":"258","article-title":"Interstitial lung disease in systemic sclerosis.","volume":"44","author":"Ooi","year":"2003","journal-title":"Acta Radiol"},{"key":"R58-20260917","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.42861","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases.","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"R59-20260917","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12016-020-08831-4","article-title":"Clinical treatment options in scleroderma: recommendations and comprehensive review.","volume":"62","author":"Zhao","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"R60-20260917","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease - a case series with follow-up.","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"key":"R61-20260917","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1056\/NEJMoa2414108","article-title":"Nerandomilast in patients with idiopathic pulmonary fibrosis.","volume":"392","author":"Richeldi","year":"2025","journal-title":"N Engl J Med"},{"key":"R62-20260917","doi-asserted-by":"crossref","first-page":"102403","DOI":"10.1016\/j.autrev.2019.102403","article-title":"Is there today a place for corticosteroids in the treatment of scleroderma?","volume":"18","author":"Blagojevic","year":"2019","journal-title":"Autoimmun Rev"},{"key":"R63-20260917","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1164\/rccm.202306-1113ST","article-title":"Treatment of systemic sclerosis-associated interstitial lung disease: evidence-based recommendations. an official american thoracic society clinical practice guideline.","volume":"209","author":"Raghu","year":"2024","journal-title":"Am J Respir Crit Care Med"},{"key":"R64-20260917","doi-asserted-by":"crossref","first-page":"e0124205","DOI":"10.1371\/journal.pone.0124205","article-title":"Safety and effectiveness of mycophenolate in systemic sclerosis. A systematic review.","volume":"10","author":"Omair","year":"2015","journal-title":"PLoS One"},{"key":"R65-20260917","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1513\/AnnalsATS.202301-056OC","article-title":"Tocilizumab in patients with systemic sclerosis-associated interstitial lung disease: a systematic review and meta-analysis.","volume":"21","author":"Ghazipura","year":"2024","journal-title":"Ann Am Thorac Soc"},{"key":"R66-20260917","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00296-020-04565-w","article-title":"Efficacy and safety of pirfenidone in systemic sclerosis-related interstitial lung disease-a randomised controlled trial.","volume":"40","author":"Acharya","year":"2020","journal-title":"Rheumatol Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050368","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T06:00:31Z","timestamp":1789624831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050368"}},"subtitle":["A two-decade analysis of clinical and radiologic characteristics"],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":66,"journal-issue":{"issue":"34","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050368","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2025-11-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}